A.P. Pharma About
A.P. Pharma: A.P. Pharma, Inc. (NASDAQ NM: APPA)
is a specialty pharmaceutical company
focused on the development and commercialization
of innovative medical treatments utilizing
its proprietary polymer-based drug delivery
systems. The Company's primary emphasis is on
advancing its Biochronomer™ technology
platform for site-specific and systemic
drug delivery. Designed to release drugs
over a period of hours, days, weeks or
even months, Biochronomer systems can
be fabricated into a wide range of forms,
ranging from solid strands to free-flowing
gels which erode away as they deliver
the drug. A variety of injectable and
implantable applications are undergoing
feasibility testing to address major unmet
needs in pain management, post-chemotherapy
nausea and vomiting, inflammation, device
coating, ophthalmology and other medical
fields. Pipeline
Chart for A.P. Pharma Pipeline:
Phase
II (completed)
Mepivacaine
APF112
- Acute pain relief (surgical/ orthopedic)
Phase
I (completed)
Granisetron
APF530
- Anti-nausea (chemotherapy/surgical)
More on A.P. Pharma: